Stormgen Pharmaceuticals Private Limited

Stormgen Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24100TG2021PTC148697 Incorporated 16 February 2021 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2024
₹6.85 Lakh
▼ 48% YoY
Net loss · FY 2024
₹6.36 Lakh
Net margin -92.8%
EBITDA · FY 2024
-₹6.07 Lakh
EBITDA margin -88.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Stormgen Pharmaceuticals Private Limited

Data last updated:

Stormgen Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 February 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2021PTC148697.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Harsha Vardan Reddy Mahakala and Pradeep Mahakala.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 502 Vijay Sai Seva Residency Jp Nagar Miyapur, Hyderabad, Telangana, India – 500049.

As per the financials filed for FY 2024, the company reported a revenue of ₹6.85 Lakh, a decline of 48% compared to the previous year. For the same year it recorded a net loss of ₹6.36 Lakh (net margin -92.8%) and EBITDA of -₹6.07 Lakh (EBITDA margin -88.6%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years.

Stormgen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0013325).

Company details

CIN U24100TG2021PTC148697
Registration Number 148697
Incorporation Date 16 February 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0013325
Key People
Harsha Vardan Reddy Mahakala Director Pradeep Mahakala Director Chirra Suchithra Reddy Director

Recognitions & Rankings of Stormgen Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-09-0013325

Contact details

Stormgen Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    Flat No 502 Vijay Sai Seva Residency Jp Nagar Miyapur, Hyderabad, Telangana, India – 500049
  • Industry
    Chemicals, Manufacturing, Basic Chemical
Comprehensive company report
Stormgen Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Stormgen Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Stormgen Pharmaceuticals Private Limited, buy the company report.

Financials of Stormgen Pharmaceuticals Private Limited

FY 2025 filings available

Stormgen Pharmaceuticals Private Limited reported revenue of ₹6.85 Lakh (down 48% YoY) for FY 2024.

Revenue · FY 2024
₹6.85 Lakh ▼ 48%
Net loss · FY 2024
₹6.36 Lakh margin -92.8%
EBITDA · FY 2024
-₹6.07 Lakh margin -88.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 48%
3 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▼ 237%

Revenue fell 48% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 27%. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹6.07 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹6.36 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-88.6%
Net Profit Margin-92.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Stormgen Pharmaceuticals Private Limited, buy the company report.

Board of directors of Stormgen Pharmaceuticals Private Limited

Stormgen Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Harsha Vardan Reddy MahakalaDirector16 Feb 20215 Years 8 MonthsCurrent
Pradeep MahakalaDirector16 Feb 20215 Years 8 MonthsCurrent
Chirra Suchithra ReddyDirector16 Feb 20215 Years 8 MonthsCurrent
Yashwanth Reddy MahakalaDirector17 Feb 20215 Years 8 MonthsCurrent
View all directors

Peer comparison

Stormgen Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Martin and Harris Pharmaceuticals Private Limited₹6.87 Lakh (FY 2022)15.0%Mohali, Punjab, India
Stormgen Pharmaceuticals Private Limitedthis company₹6.85 Lakh (FY 2024)-₹6.36 Lakh-92.8%-48.0%Hyderabad, Telangana, India
Afromax Pharmaceuticals Private Limited₹6.84 Lakh (FY 2025)2.0%Patna, Bihar, India
Liman Pharmaceuticals Private Limited₹6.8 Lakh (FY 2025)-36.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Stormgen Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Stormgen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Stormgen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Stormgen Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Yashwanth Reddy Mahakala was appointed as Director on 17 Feb 2021.

AGM
Stormgen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stormgen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Yashwanth Reddy Mahakala was appointed as Director.
Appointed
Chirra Suchithra Reddy was appointed as Director.
Appointed
Harsha Vardan Reddy Mahakala was appointed as Director.
Appointed
Pradeep Mahakala was appointed as Director.
Incorporation
16 Feb 2021
Stormgen Pharmaceuticals Private Limited was registered on 16 Feb 2021 with Roc Hyderabad & aged 5 years 8 months as per MCA records.

Frequently asked questions

Stormgen Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 February 2021 (5+ years old) and is registered under CIN U24100TG2021PTC148697.

Stormgen Pharmaceuticals has 4 current directors:

The latest financial statements of Stormgen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Stormgen Pharmaceuticals is U24100TG2021PTC148697. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Stormgen Pharmaceuticals was incorporated on 16 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Stormgen Pharmaceuticals by revenue are Martin and Harris Pharmaceuticals Private Limited, Afromax Pharmaceuticals Private Limited, Liman Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Yashwanth Reddy Mahakala was appointed as Director on 17 Feb 2021. Chirra Suchithra Reddy was appointed as Director on 16 Feb 2021. Harsha Vardan Reddy Mahakala was appointed as Director on 16 Feb 2021. Stormgen Pharmaceuticals has 4 board changes on record in total.

Yes, Stormgen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0013325).

The registered office of Stormgen Pharmaceuticals is at Flat No 502 Vijay Sai Seva Residency Jp Nagar Miyapur, Hyderabad, Telangana, India – 500049.

Stormgen Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Stormgen Pharmaceuticals can be reached at its registered office: Flat No 502 Vijay Sai Seva Residency Jp Nagar Miyapur, Hyderabad, Telangana, India – 500049.